Stay updated on Nivolumab for Recurrent Rare CNS Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6. This is a minor system update with no changes to visible content.
    Difference
    0.0%
    Check dated 2026-08-30T07:01:24.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The study status was updated to Terminated due to no drug supply, with results posted. New data-sharing plans and updated study documents (Informed Consent Form and Protocol) were added.
    Difference
    9%
    Check dated 2026-08-23T04:01:10.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.4 to v3.6.5, reflecting a new version of the page. This is a metadata update and does not alter the study content.
    Difference
    0.1%
    Check dated 2026-08-08T22:44:49.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.6.4 replaces the previous v3.6.3. This signals a minor platform update that does not modify the study information displayed on the page.
    Difference
    0.1%
    Check dated 2026-07-25T12:37:05.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, indicating the study record has been updated to the latest revision. This change reflects a metadata revision on the page rather than an update to the substantive study information.
    Difference
    0.1%
    Check dated 2026-07-04T04:13:50.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The revision label changed from v3.6.0 to v3.6.2, indicating a minor page/system update.
    Difference
    0.1%
    Check dated 2026-06-27T01:41:09.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent Rare CNS Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.